Micro-Sphere to boost its spray drying capabilities
CDMO to invest over €3 million in GMP facility expansion.
Spray drying specialist and capsule filling service provider Micro-Sphere is investing 3.5 million CHF (€3.2 million) into expanding its GMP manufacturing capabilities and processes.
Micro-Sphere will add an additional spray drying line to its facility in Switzerland in response to increased market demand for spray drying and capsule filling for dry powder inhalers.
The new production line, expected to be operational by Q1 2021, is Micro-Sphere’s fifth and will allow the CDMO to handle larger quantities of pharmaceutical powders and commercial volumes of finished dosage forms.
Commenting on the investment, Michael Grassberger, Managing Director at Micro-Sphere said: “Our decision to invest has been fuelled by greater demand for spray drying services and we expect it will generate significant benefits for our clients. Our flexibility is key to our success and this investment allows us to maintain that competitive advantage.”
The Swiss facility, already home to some of the world’s leading spray drying and capsule filling technologies, will also benefit from the introduction of a new enterprise resource planning (ERP) system and ‘Chromeleon’ a Chromatografy Data System (CDS) software to support the QC Lab workflow.
Both software systems will bring significant cost and time savings to the business and streamline process efficiency.
Michael Grassberger added: “This year we have focused on making the necessary investments to prepare Micro-Sphere for growth in 2019 and beyond. As well as investing in new machinery to increase our capabilities and expertise, we have also made significant investment into the latest technology. This includes investing in software platforms to ensure the most efficient and robust quality and documentation management systems are in place.
“At Micro-Sphere we’re committed to client satisfaction and ensuring our customers continue to receive the efficient and flexible service that they’re used to, so we’re always looking for ways to further improve our operations to allow us to better cater for their projects.
“This investment further demonstrates our commitment to meeting and exceeding the expectations of our customers and our experienced team are very excited to bring these investments into operation.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance